These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1075 related articles for article (PubMed ID: 27345407)

  • 1. Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer.
    Chouaib S; Noman MZ; Kosmatopoulos K; Curran MA
    Oncogene; 2017 Jan; 36(4):439-445. PubMed ID: 27345407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia as a potential inducer of immune tolerance, tumor plasticity and a driver of tumor mutational burden: Impact on cancer immunotherapy.
    Abou Khouzam R; Janji B; Thiery J; Zaarour RF; Chamseddine AN; Mayr H; Savagner P; Kieda C; Gad S; Buart S; Lehn JM; Limani P; Chouaib S
    Semin Cancer Biol; 2023 Dec; 97():104-123. PubMed ID: 38029865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Autophagy in the Tumor Microenvironment: New Challenges and Opportunities for Regulating Tumor Immunity.
    Janji B; Berchem G; Chouaib S
    Front Immunol; 2018; 9():887. PubMed ID: 29922284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Hypoxic Stress in Regulating Tumor Immunogenicity, Resistance and Plasticity.
    Terry S; Faouzi Zaarour R; Hassan Venkatesh G; Francis A; El-Sayed W; Buart S; Bravo P; Thiery J; Chouaib S
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30301213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to Hypoxia.
    Noman MZ; Hasmim M; Messai Y; Terry S; Kieda C; Janji B; Chouaib S
    Am J Physiol Cell Physiol; 2015 Nov; 309(9):C569-79. PubMed ID: 26310815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving Cancer Immunotherapy by Targeting the Hypoxic Tumor Microenvironment: New Opportunities and Challenges.
    Noman MZ; Hasmim M; Lequeux A; Xiao M; Duhem C; Chouaib S; Berchem G; Janji B
    Cells; 2019 Sep; 8(9):. PubMed ID: 31540045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microenvironmental hypoxia orchestrating the cell stroma cross talk, tumor progression and antitumor response.
    Noman MZ; Messai Y; Carré T; Akalay I; Méron M; Janji B; Hasmim M; Chouaib S
    Crit Rev Immunol; 2011; 31(5):357-77. PubMed ID: 22142164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor Hypoxia: A Key Determinant of Microenvironment Hostility and a Major Checkpoint during the Antitumor Response.
    Francis A; Venkatesh GH; Zaarour RF; Zeinelabdin NA; Nawafleh HH; Prasad P; Buart S; Terry S; Chouaib S
    Crit Rev Immunol; 2018; 38(6):505-524. PubMed ID: 31002604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting hypoxia in the tumor microenvironment: a potential strategy to improve cancer immunotherapy.
    Wang B; Zhao Q; Zhang Y; Liu Z; Zheng Z; Liu S; Meng L; Xin Y; Jiang X
    J Exp Clin Cancer Res; 2021 Jan; 40(1):24. PubMed ID: 33422072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxic Stress-Induced Tumor and Immune Plasticity, Suppression, and Impact on Tumor Heterogeneity.
    Terry S; Buart S; Chouaib S
    Front Immunol; 2017; 8():1625. PubMed ID: 29225600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating tumor hypoxic stress in novel and more adaptable strategies for cancer immunotherapy.
    Abou Khouzam R; Goutham HV; Zaarour RF; Chamseddine AN; Francis A; Buart S; Terry S; Chouaib S
    Semin Cancer Biol; 2020 Oct; 65():140-154. PubMed ID: 31927131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Antitumor Cytotoxic Response: If the Killer Cells Play the Music, the Microenvironmental Hypoxia Plays the Tune.
    Chouaib S
    Crit Rev Immunol; 2020; 40(2):157-166. PubMed ID: 32749093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-modulatory nanomaterials to relieve tumor hypoxic microenvironment and enhance immunotherapy: Where do we stand?
    Yuan CS; Deng ZW; Qin D; Mu YZ; Chen XG; Liu Y
    Acta Biomater; 2021 Apr; 125():1-28. PubMed ID: 33639310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moving Immune Therapy Forward Targeting TME.
    Goliwas KF; Deshane JS; Elmets CA; Athar M
    Physiol Rev; 2021 Apr; 101(2):417-425. PubMed ID: 32790578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia-induced autophagy: a new player in cancer immunotherapy?
    Noman MZ; Janji B; Berchem G; Mami-Chouaib F; Chouaib S
    Autophagy; 2012 Apr; 8(4):704-6. PubMed ID: 22441015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Promise of Targeting Hypoxia to Improve Cancer Immunotherapy: Mirage or Reality?
    Janji B; Chouaib S
    Front Immunol; 2022; 13():880810. PubMed ID: 35795658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale for Combining Radiotherapy and Immune Checkpoint Inhibition for Patients With Hypoxic Tumors.
    Eckert F; Zwirner K; Boeke S; Thorwarth D; Zips D; Huber SM
    Front Immunol; 2019; 10():407. PubMed ID: 30930892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-Driven Immune Escape in the Tumor Microenvironment.
    Vito A; El-Sayes N; Mossman K
    Cells; 2020 Apr; 9(4):. PubMed ID: 32316260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions.
    Chen Z; Han F; Du Y; Shi H; Zhou W
    Signal Transduct Target Ther; 2023 Feb; 8(1):70. PubMed ID: 36797231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia-driven intratumor heterogeneity and immune evasion.
    Terry S; Engelsen AST; Buart S; Elsayed WS; Venkatesh GH; Chouaib S
    Cancer Lett; 2020 Nov; 492():1-10. PubMed ID: 32712233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.